AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
REDUCED STRIATAL DOPAMINE TRANSPORTER DENSITY IN ABSTINENT METHAMPHETAMINE AND METHCATHINONE USERS - EVIDENCE FROM POSITRON-EMISSION-TOMOGRAPHY STUDIES WITH [C-11] WIN-35,428
Authors: MCCANN UD WONG DF YOKOI F VILLEMAGNE V DANNALS RF RICAURTE GA
Citation: Ud. Mccann et al., REDUCED STRIATAL DOPAMINE TRANSPORTER DENSITY IN ABSTINENT METHAMPHETAMINE AND METHCATHINONE USERS - EVIDENCE FROM POSITRON-EMISSION-TOMOGRAPHY STUDIES WITH [C-11] WIN-35,428, The Journal of neuroscience, 18(20), 1998, pp. 8417-8422
INHIBITION OF AMPHETAMINE-INDUCED DOPAMINE RELEASE BY GBR-12909
Authors: VILLEMAGNE VL ROTHMAN RB YOKOI F CLOUGH D RICE KC MATECKA D STEPHANE M WONG DF
Citation: Vl. Villemagne et al., INHIBITION OF AMPHETAMINE-INDUCED DOPAMINE RELEASE BY GBR-12909, The Journal of nuclear medicine, 39(5), 1998, pp. 210-210
IN-VIVO IMAGING OF PRIMATE CEREBRAL ALPHA-2-ADRENERGIC RECEPTORS USING [C11]P11432
Authors: WONG DF MUSACHIO JL VARGAS HM YOKOI F VILLEMAGNE V SCHEFFEL U STEPHANE M DOGAN S DANNALS RF OFFORD SJ NATARAJAN C
Citation: Df. Wong et al., IN-VIVO IMAGING OF PRIMATE CEREBRAL ALPHA-2-ADRENERGIC RECEPTORS USING [C11]P11432, The Journal of nuclear medicine, 39(5), 1998, pp. 278-278
RADIOLABELED NEURONAL NITRIC-OXIDE SYNTHASE INHIBITORS - SYNTHESIS, IN-VIVO EVALUATION AND PRIMATE PET STUDIES
Authors: POMPER MG MUSACHIO JL SCHEFFEL U MACDONALD JE MCCARTHY D REIF D VILLEMAGNE V YOKOI F DANNALS RF WONG DF
Citation: Mg. Pomper et al., RADIOLABELED NEURONAL NITRIC-OXIDE SYNTHASE INHIBITORS - SYNTHESIS, IN-VIVO EVALUATION AND PRIMATE PET STUDIES, The Journal of nuclear medicine, 39(5), 1998, pp. 539-539
EFFECT OF MAZINDOL ON DOPAMINE TRANSPORTER IN NORMAL HUMAN BRAIN - GRAPHIC KINETIC MODELING FOR [C11]WIN-35,428 WITH NO BLOOD INPUT
Authors: YOKOI F DOGAN AS STEPHANE M CHEN A WONG DF
Citation: F. Yokoi et al., EFFECT OF MAZINDOL ON DOPAMINE TRANSPORTER IN NORMAL HUMAN BRAIN - GRAPHIC KINETIC MODELING FOR [C11]WIN-35,428 WITH NO BLOOD INPUT, The Journal of nuclear medicine, 39(5), 1998, pp. 759-759
3-PHOSPHOHISTIDINE AND 6-PHOSPHOLYSINE ARE SUBSTRATES OF A 56-KDA INORGANIC PYROPHOSPHATASE FROM BOVINE LIVER
Authors: HIRAISHI H YOKOI F KUMON A
Citation: H. Hiraishi et al., 3-PHOSPHOHISTIDINE AND 6-PHOSPHOLYSINE ARE SUBSTRATES OF A 56-KDA INORGANIC PYROPHOSPHATASE FROM BOVINE LIVER, Archives of biochemistry and biophysics, 349(2), 1998, pp. 381-387
MULTIPLE LINES OF EVIDENCE FOR DOPAMINE DYSFUNCTION IN PSYCHOSIS BY IMAGING
Authors: WONG DF GJEDDE A REITH J GRUNDER G SZYMANSKI S YOKOI F HONG C NESTADT G NEUFELD K PEARLSON G TUNE L ANGRIST B
Citation: Df. Wong et al., MULTIPLE LINES OF EVIDENCE FOR DOPAMINE DYSFUNCTION IN PSYCHOSIS BY IMAGING, Schizophrenia research, 24(1-2), 1997, pp. 183-183
TIME-COURSE OF 5-HT2A RECEPTOR OCCUPANCY IN THE HUMAN BRAIN AFTER A SINGLE ORAL DOSE OF THE PUTATIVE ANTIPSYCHOTIC DRUG MDL-100,907 MEASURED BY POSITRON EMISSION TOMOGRAPHY
Authors: GRUNDER G YOKOI F OFFORD SJ RAVERT HT DANNALS RF SALZMANN JK SZYMANSKI S WILSON PD HOWARD DR WONG DF
Citation: G. Grunder et al., TIME-COURSE OF 5-HT2A RECEPTOR OCCUPANCY IN THE HUMAN BRAIN AFTER A SINGLE ORAL DOSE OF THE PUTATIVE ANTIPSYCHOTIC DRUG MDL-100,907 MEASURED BY POSITRON EMISSION TOMOGRAPHY, Neuropsychopharmacology, 17(3), 1997, pp. 175-185
INCREASED INTRASYNAPTIC DOPAMINE RELEASE IN TOURETTES-SYNDROME
Authors: SINGER HS SZYMANSKI S GIULIANO J DOGAN S YOKOI F VILLEMAGNE V CHIN B KIRSCH J GJEDDE A WONG DF
Citation: Hs. Singer et al., INCREASED INTRASYNAPTIC DOPAMINE RELEASE IN TOURETTES-SYNDROME, Annals of neurology, 42(3), 1997, pp. 104-104
THE EFFECT OF INTRASYNAPTIC DOPAMINE RELEASE ON MEASURING B-MAX AND B-MAX K(D) IN SCHIZOPHRENIA BY PET/
Authors: WONG DF YOKOI F GRUNDER G HONG C SZYMANSKI S DOGUN A NESTADT G NEUFELD K GJEDDE A
Citation: Df. Wong et al., THE EFFECT OF INTRASYNAPTIC DOPAMINE RELEASE ON MEASURING B-MAX AND B-MAX K(D) IN SCHIZOPHRENIA BY PET/, The Journal of nuclear medicine, 38(5), 1997, pp. 32-32
BASAL GANGLIA DOPAMINE RELEASE IN TOURETTE-SYNDROME
Authors: SZYMANSKI S SINGER H GIULIANO J YOKOI F DOGAN S VILLEMAGNE V CHIN B GJEDDE A WONG DF
Citation: S. Szymanski et al., BASAL GANGLIA DOPAMINE RELEASE IN TOURETTE-SYNDROME, The Journal of nuclear medicine, 38(5), 1997, pp. 35-35
SUBSTANTIAL OCCUPANCY OF DOPAMINE TRANSPORTERS BY GBR12909, A POTENTIAL TREATMENT AGENT FOR COCAINE ADDICTION, AS MEASURED BY PET
Authors: VILLEMAGNE VL ROTHMAN RB YOKOI F FINLEY P RICE KC CHEN A MATECKA D RAVERT HT MATHEWS WB MUSACHIO JL DANNALS RF WONG DF
Citation: Vl. Villemagne et al., SUBSTANTIAL OCCUPANCY OF DOPAMINE TRANSPORTERS BY GBR12909, A POTENTIAL TREATMENT AGENT FOR COCAINE ADDICTION, AS MEASURED BY PET, The Journal of nuclear medicine, 38(5), 1997, pp. 123-123
DOPAMINE TERMINAL LOSS IN METHAMPHETAMINE-TREATED BABOONS - A PET STUDY WITH C-11 WIN-35,428
Authors: VILLEMAGNE VL YOKOI F FINLEY P HATZIDIMITRIOU G CLOUGH DJ RAVERT HT MATHEWS WB MUSACHIO JL DANNALS RF RICAURTE G WONG DF
Citation: Vl. Villemagne et al., DOPAMINE TERMINAL LOSS IN METHAMPHETAMINE-TREATED BABOONS - A PET STUDY WITH C-11 WIN-35,428, The Journal of nuclear medicine, 38(5), 1997, pp. 349-349
CONSIDERATIONS FOR MEASURING DOPAMINE BINDING POTENTIAL WITH PET IN THE STRIATA OF PRIMATES SMALLER THAN HUMANS
Authors: CHEFER SI MORRIS ED WONG DF INGRAM DK ROTH G LANE M MUZIC RF GRANT S WEYL L MATOCHIK J VILLEMAGNE V YOKOI F DANNALS RF LONDON ED
Citation: Si. Chefer et al., CONSIDERATIONS FOR MEASURING DOPAMINE BINDING POTENTIAL WITH PET IN THE STRIATA OF PRIMATES SMALLER THAN HUMANS, The Journal of nuclear medicine, 38(5), 1997, pp. 1141-1141
EFFECT OF CHOLINESTERASE-INHIBITORS ON BINDING TO NICOTINIC ACETYLCHOLINE-RECEPTORS IN HUMAN BRAIN - A PET COMPARISON
Authors: YOKOI F SZYMANSKI S OFFORD SJ GRUNDER G DOGAN AS RAVERT HT DANNALS RF LONDON ED GJEDDE A WONG DF
Citation: F. Yokoi et al., EFFECT OF CHOLINESTERASE-INHIBITORS ON BINDING TO NICOTINIC ACETYLCHOLINE-RECEPTORS IN HUMAN BRAIN - A PET COMPARISON, The Journal of nuclear medicine, 38(5), 1997, pp. 1215-1215
A BABOON BRAIN ATLAS OF MRI PET AND TISSUE-SECTIONS - A GUIDE FOR FUNCTIONAL-STUDIES
Authors: DOGAN AS SAHINOGLU K MOUTON PR VILLEMAGNE V YOKOI F WONG DF
Citation: As. Dogan et al., A BABOON BRAIN ATLAS OF MRI PET AND TISSUE-SECTIONS - A GUIDE FOR FUNCTIONAL-STUDIES, The Journal of nuclear medicine, 38(5), 1997, pp. 1303-1303
PURIFICATION AND CHARACTERIZATION OF HEPATIC INORGANIC PYROPHOSPHATASE HYDROLYZING IMIDODIPHOSPHATE
Authors: HIRAISHI H OHMAGARI T OTSUKA Y YOKOI F KUMON A
Citation: H. Hiraishi et al., PURIFICATION AND CHARACTERIZATION OF HEPATIC INORGANIC PYROPHOSPHATASE HYDROLYZING IMIDODIPHOSPHATE, Archives of biochemistry and biophysics, 341(1), 1997, pp. 153-159
COMPARISON OF 4 DOPAMINE-D2 OCCUPANCY MEASUREMENTS USING NO INPUT FUNCTION
Authors: YOKOI F BIZIERE K GRUNDEN G SHAYA E DANNALS RF RAVERT H ICHISE M KRASENBAUM DN WONG DF
Citation: F. Yokoi et al., COMPARISON OF 4 DOPAMINE-D2 OCCUPANCY MEASUREMENTS USING NO INPUT FUNCTION, The Journal of nuclear medicine, 37(5), 1996, pp. 297-297
IMAGING HUMAN CEREBRAL SEROTONIN 5-HT2A RECEPTORS WITH C-11 MDL-100907
Authors: WONG DF GRUNDER G YOKOI F SZYMANSKI S RAVERT HT MATHEWS WB MUSACHIO KL SCHEFFEL U DANNALS RF
Citation: Df. Wong et al., IMAGING HUMAN CEREBRAL SEROTONIN 5-HT2A RECEPTORS WITH C-11 MDL-100907, The Journal of nuclear medicine, 37(5), 1996, pp. 438-438
HUMAN 5-HT1A RECEPTOR OCCUPANCY AFTER A SINGLE-DOSE OF A PUTATIVE ATYPICAL ANTIPSYCHOTIC MDL-100907
Authors: GRUNDER G YOKOI F OFFORD SJ SALZMANN JK KRASENBAUM DN SZYMANSKI S RAVERT HT DANNALS RF WONG DF
Citation: G. Grunder et al., HUMAN 5-HT1A RECEPTOR OCCUPANCY AFTER A SINGLE-DOSE OF A PUTATIVE ATYPICAL ANTIPSYCHOTIC MDL-100907, The Journal of nuclear medicine, 37(5), 1996, pp. 439-439
EFFECTS OF SAFFAN AND ISOFLURANE ON [H3]RACLOPRIDE AND [H3] NMSP BINDING IN MOUSE-BRAIN
Authors: YOKOI F FINLEY P STATHIS M CHEN A YASTER M SCHEFFEL U LONDON ED WONG DF
Citation: F. Yokoi et al., EFFECTS OF SAFFAN AND ISOFLURANE ON [H3]RACLOPRIDE AND [H3] NMSP BINDING IN MOUSE-BRAIN, The Journal of nuclear medicine, 37(5), 1996, pp. 1245-1245
A COMPARISON OF 2 METHODS OF GRAPHICAL ANALYSIS AND A NONLINEAR CONSTRAINED METHOD FOR ESTIMATION OF HUMAN [C11]RACLOPRIDE BINDING POTENTIAL
Authors: YOKOI F ICHISE M CHAN B KALAFF A ROSENBERG JM CHEN A RAVERT HT DANNALS RF WONG DF
Citation: F. Yokoi et al., A COMPARISON OF 2 METHODS OF GRAPHICAL ANALYSIS AND A NONLINEAR CONSTRAINED METHOD FOR ESTIMATION OF HUMAN [C11]RACLOPRIDE BINDING POTENTIAL, The Journal of nuclear medicine, 37(5), 1996, pp. 1250-1250
CORRECTION FOR PARTIAL VOLUME EFFECTS ON BINDING POTENTIAL MEASUREMENTS WITH HUMAN [C11]RACLOPRIDE PET
Authors: YOKOI F ROUSSET O HONG C SIMAKHODSKI I CHAN B GJEDDE A EVANS A WONG DF
Citation: F. Yokoi et al., CORRECTION FOR PARTIAL VOLUME EFFECTS ON BINDING POTENTIAL MEASUREMENTS WITH HUMAN [C11]RACLOPRIDE PET, The Journal of nuclear medicine, 37(5), 1996, pp. 1263-1263
DOPAMINE TRANSPORTERS ARE MARKEDLY REDUCED IN LESCH-NYHAN DISEASE IN-VIVO
Authors: WONG DF HARRIS JC NAIDU S YOKOI F MARENCO S DANNALS RF RAVERT HT YASTER M EVANS A ROUSSET O BRYAN RN GJEDDE A KUHAR MJ BREESE GR
Citation: Df. Wong et al., DOPAMINE TRANSPORTERS ARE MARKEDLY REDUCED IN LESCH-NYHAN DISEASE IN-VIVO, Proceedings of the National Academy of Sciences of the United Statesof America, 93(11), 1996, pp. 5539-5543
N-OMEGA-PHOSPHOARGININE PHOSPHATASE (17 KDA) AND ALKALINE-PHOSPHATASEAS PROTEIN ARGININE PHOSPHATASES
Authors: KUMON A KODAMA H KONDO M YOKOI F HIRAISHI H
Citation: A. Kumon et al., N-OMEGA-PHOSPHOARGININE PHOSPHATASE (17 KDA) AND ALKALINE-PHOSPHATASEAS PROTEIN ARGININE PHOSPHATASES, Journal of Biochemistry, 119(4), 1996, pp. 719-724
Risultati: 1-25 | 26-32